肾移植受者干扰素给药的双盲研究。
Double-blind study of interferon administration in renal transplant recipients.
作者信息
Weimar W, Schellekens H, Lameijer L D, Masurel N, Edy V G, Billiau A, De Somer P
出版信息
Eur J Clin Invest. 1978 Aug;8(4):255-8. doi: 10.1111/j.1365-2362.1978.tb00861.x.
Abstract
In a double-blind trial renal allograft recipients were treated with fibroblast interferon preparations for 3 months in an attempt to prevent viral infections. Interferon therapy did not reduce the overall incidence of viral infections. No adverse effects were noted on liver function, platelet counts, or leucocyte counts, or acute rejection episodes.
摘要
在一项双盲试验中，肾移植受者接受了成纤维细胞干扰素制剂治疗3个月，以试图预防病毒感染。干扰素治疗并未降低病毒感染的总体发生率。未观察到对肝功能、血小板计数、白细胞计数或急性排斥反应有不良影响。
Zotero 插件